Literature DB >> 12550805

In Check Dial: accuracy for Diskus and Turbuhaler.

Marielle E A C Broeders1, Johan Molema, Niek A Vermue, Hons Th M Folgering.   

Abstract

OBJECTIVE: The In Check Dial was developed to evaluate whether a patient is able to generate an adequate peak inspiratory flow (PIF) through a certain inhalation device. The inhalation profile recorder (IPR) is a calibrated instrument that measures flows through Diskus and Turbuhaler in our research setting. The aim of this study was to compare the PIFs of patients when inhaling through a Diskus or Turbuhaler connected with the IPR (PIF_diskus and PIF_TH) to the flows through the corresponding orifices of the In Check Dial (Diskus_In Check and TH_In Check).
METHODS: Twenty-four stable asthma and twenty-one chronic obstructive pulmonary disease (COPD) patients inhaled, on two separate occasions, in randomised order, via the Diskus or Turbuhaler connected with the IPR. Subsequently, patients inhaled through the In Check Dial using the orifices of Diskus or Turbuhaler.
RESULTS: The difference between Diskus_In Check and PIF_diskus was 3.9 (11.9)l/min (P=0.038). The difference between TH_In Check and PIF_TH was 3.5 (10.6) l/min (NS). All Diskus- and Turbuhaler-inhalations were performed with the minimum required flow of 30 l/min. However, four COPD patients inhaled with the non-optimal flow (<60 l/min) through the Turbuhaler. The In Check Dial did not indicate two of them.
CONCLUSION: Measuring PIF through Diskus and Turbuhaler using the IPR and the In Check Dial, respectively shows a disagreement of 3.9l/min. A disagreement of 3.5l/min was found for the Turbuhaler. The In Check Dial did not identify two of four patients as 'non-optimal' users.

Entities:  

Mesh:

Year:  2003        PMID: 12550805     DOI: 10.1016/s0378-5173(02)00650-6

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

Review 1.  Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.

Authors:  Sohini Ghosh; Jill A Ohar; M Bradley Drummond
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-09-21       Impact factor: 2.849

2.  Reduced Peak Inspiratory Effort through the Diskus((R)) and the Turbuhaler((R)) due to Mishandling is Common in Clinical Practice.

Authors:  Andrea S Melani; Letizia S Bracci; Marcello Rossi
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

3.  Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.

Authors:  Jansen N Seheult; Simon Costello; Kee Chun Tee; Tariq Bholah; Hasan Al Bannai; Imran Sulaiman; Richard W Costello
Journal:  Springerplus       Date:  2014-09-02

4.  Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.

Authors:  Theerasuk Kawamatawong; Supattra Khiawwan; Prapaporn Pornsuriyasak
Journal:  J Asthma Allergy       Date:  2017-02-23

5.  Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.

Authors:  Jianlan Hua; Wei Zhang; Hui-Fang Cao; Chun-Ling Du; Jia-Yun Ma; Yi-Hui Zuo; Jing Zhang
Journal:  BMJ Open       Date:  2020-05-07       Impact factor: 2.692

6.  Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Arash Samarghandi; Octavian C Ioachimescu; Rehan Qayyum
Journal:  PLoS One       Date:  2020-01-31       Impact factor: 3.240

7.  Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD.

Authors:  Cristina Represas-Represas; Luz Aballe-Santos; Alberto Fernández-García; Ana Priegue-Carrera; José-Luis López-Campos; Almudena González-Montaos; Maribel Botana-Rial; Alberto Fernández-Villar
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

8.  Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study.

Authors:  Swapna Mandal; John R Hurst; Jaber S Alqahtani; Yousef S Aldabayan; Abdulelah M Aldhahir; Ahmad M Al Rajeh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-07

9.  The clinical utility of forced oscillation technique during hospitalisation in patients with exacerbation of COPD.

Authors:  Jaber S Alqahtani; Ahmad M Al Rajeh; Abdulelah M Aldhahir; Yousef S Aldabayan; John R Hurst; Swapna Mandal
Journal:  ERJ Open Res       Date:  2021-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.